Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

NCT07370922 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Transfusion Dependent Beta Thalassemia

Interventions

DRUG: Dulaglutide 0.75Mg/0.5Ml Inj Pen
DRUG: control group (insulin)

Sponsor

Ain Shams University